Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 Mar 2024
06 Mar 2024
Historique:
received:
05
11
2023
accepted:
27
02
2024
medline:
7
3
2024
pubmed:
7
3
2024
entrez:
6
3
2024
Statut:
epublish
Résumé
Biological samples are often frozen and stored for years and/or thawed multiple times, thus assessing their stability on long-term storage and repeated freeze-thaw cycles is crucial. The study aims were to assess:-the long-term stability of two major enzymatic and non-enzymatic metabolites of arachidonic acid, i.e. urinary 11-dehydro-thromboxane-(Tx) B
Identifiants
pubmed: 38448541
doi: 10.1038/s41598-024-55720-3
pii: 10.1038/s41598-024-55720-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5546Subventions
Organisme : catholic university school of medicine, Rome, Italy
ID : Linea D1 2021 and Linea D1 2022
Organisme : catholic university school of medicine, Rome, Italy
ID : Linea D1 2021 and Linea D1 2022
Organisme : AsCaP collaboration
ID : C569/A24991#2
Organisme : AsCaP collaboration
ID : C569/A24991#2
Informations de copyright
© 2024. The Author(s).
Références
Patrono, C. et al. Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb. Res. 17, 317–327 (1980).
pubmed: 7368167
doi: 10.1016/0049-3848(80)90066-3
Badimon, L., Vilahur, G., Rocca, B. & Patrono, C. The key contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovasc. Res. 117, 2001–2015 (2021).
pubmed: 33484117
doi: 10.1093/cvr/cvab003
Roberts, L. J. 2nd., Sweetman, B. J. & Oates, J. A. Metabolism of thromboxane B2 in man. Identification of twenty urinary metabolites. J. Biol. Chem. 256, 8384–8393 (1981).
pubmed: 7263660
doi: 10.1016/S0021-9258(19)68855-1
Ciabattoni, G. et al. Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man. Biochim. Biophys. Acta 992, 66–70 (1989).
pubmed: 2752040
doi: 10.1016/0304-4165(89)90051-2
Catella, F. & Fitzgerald, G. A. Paired analysis of urinary thromboxane B2 metabolites in humans. Thrombosis Res. 47, 647–656 (1987).
doi: 10.1016/0049-3848(87)90103-4
Patrono, C. et al. Estimated rate of thromboxane secretion into the circulation of normal humans. J. Clin. Investig. 77, 590–594 (1986).
pubmed: 3944270
pmcid: 423390
doi: 10.1172/JCI112341
Patrono, C. & Rocca, B. Measurement of thromboxane biosynthesis in health and disease. Front. Pharmacol. 10, 1244 (2019).
pubmed: 31736753
pmcid: 6832017
doi: 10.3389/fphar.2019.01244
Eikelboom, J. W. et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Circulation 105, 1650–1655 (2002).
pubmed: 11940542
doi: 10.1161/01.CIR.0000013777.21160.07
Rade, J. J. et al. Association of thromboxane generation with survival in aspirin users and nonusers. J. Am. Coll. Cardiol. 80, 233–250 (2022).
pubmed: 35660296
doi: 10.1016/j.jacc.2022.04.034
Joharatnam-Hogan, N. et al. Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: A sub-study of the Add-Aspirin trial. Br. J. Cancer 129, 706–720 (2023).
pubmed: 37420000
pmcid: 10421951
doi: 10.1038/s41416-023-02310-1
Ito, F., Sono, Y. & Ito, T. Measurement and clinical significance of lipid peroxidation as a biomarker of oxidative stress: Oxidative stress in diabetes, atherosclerosis, and chronic inflammation. Antioxidants 8, 72 (2019).
pubmed: 30934586
pmcid: 6466575
doi: 10.3390/antiox8030072
Awad, J. A., Morrow, J. D., Takahashi, K. & Roberts, L. J. 2nd. Identification of non-cyclooxygenase-derived prostanoid (F2-isoprostane) metabolites in human urine and plasma. J. Biol. Chem. 268, 4161–4169 (1993).
pubmed: 8440704
doi: 10.1016/S0021-9258(18)53593-6
Davì, G., Falco, A. & Patrono, C. Determinants of F2-isoprostane biosynthesis and inhibition in man. Chem. Phys. Lipids 128, 149–163 (2004).
pubmed: 15037160
doi: 10.1016/j.chemphyslip.2003.10.001
Petrucci, G. et al. Role of oxidative stress in the pathogenesis of atherothrombotic diseases. Antioxidants 11, 1408 (2022).
pubmed: 35883899
pmcid: 9312358
doi: 10.3390/antiox11071408
Schwedhelm, E. et al. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: A matched case-control study. Circulation 109, 843–848 (2004).
pubmed: 14757688
doi: 10.1161/01.CIR.0000116761.93647.30
Roest, M. et al. High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women. J. Clin. Lipidol. 2, 298–303 (2008).
pubmed: 21291746
doi: 10.1016/j.jacl.2008.06.004
Bhatt, D. L. et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. New Engl. J. Med. 354, 1706–1717 (2006).
pubmed: 16531616
doi: 10.1056/NEJMoa060989
Wade, L. G. Organic Chemistry (Pearson Prentice Hall, 2006).
Petrucci, G. et al. Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation. J. Thrombosis Haemostasis 17, 885–895 (2019).
doi: 10.1111/jth.14445
Zaccardi, F. et al. In Vivo platelet activation and aspirin responsiveness in type 1 diabetes. Diabetes 65, 503–509 (2015).
pubmed: 26470782
doi: 10.2337/db15-0936
Santilli, F. et al. In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance. Diabetes Metab. Res. Rev. 36, e3232 (2020).
pubmed: 31671234
doi: 10.1002/dmrr.3232
Petrucci, G. et al. Platelet thromboxane inhibition by low-dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation. Clin. Transl. Sci. 15, 2958–2970 (2022).
pubmed: 36200184
pmcid: 9747129
doi: 10.1111/cts.13415
Rocca, B. et al. A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia. Blood 136, 171–182 (2020).
pubmed: 32266380
doi: 10.1182/blood.2019004596
Pagliaccia, F. et al. Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume. Clin. Lab. 60, 105–111 (2014).
pubmed: 24600983
doi: 10.7754/Clin.Lab.2013.121238
Lellouche, F., Fradin, A., Fitzgerald, G. & Maclouf, J. Enzyme immunoassay measurement of the urinary metabolites of thromboxane A2 and prostacyclin. Prostaglandins 40, 297–310 (1990).
pubmed: 2247619
doi: 10.1016/0090-6980(90)90017-P
Pradelles, P., Grassi, J. & Maclouf, J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: An alternative to radioimmunoassay. Anal. Chem. 57, 1170–1173 (1985).
pubmed: 3898913
doi: 10.1021/ac00284a003
Wang, Z. et al. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J. Pharmacol. Exp. Ther. 275, 94–100 (1995).
pubmed: 7562601
Murphy, M. P. et al. Guidelines for measuring reactive oxygen species and oxidative damage in cells and in vivo. Nat. Metab. 4, 651–662 (2022).
pubmed: 35760871
pmcid: 9711940
doi: 10.1038/s42255-022-00591-z
Association, W. M. World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA 310, 2191–2194 (2013).
doi: 10.1001/jama.2013.281053
Yan, W., Byrd, G. D. & Ogden, M. W. Quantitation of isoprostane isomers in human urine from smokers and nonsmokers by LC-MS/MS. J. Lipid Res. 48, 1607–1617 (2007).
pubmed: 17456897
doi: 10.1194/jlr.M700097-JLR200
Holder, C. et al. High-throughput and sensitive analysis of free and total 8-isoprostane in urine with isotope-dilution liquid chromatography-tandem mass spectrometry. ACS Omega 5, 10919–10926 (2020).
pubmed: 32455212
pmcid: 7241033
doi: 10.1021/acsomega.0c00661
Sieminska, J. et al. A single extraction 96-well method for LC-MS/MS quantification of urinary eicosanoids, steroids and drugs. Prostagland. Other Lipid Mediat. 170, 106789 (2023).
doi: 10.1016/j.prostaglandins.2023.106789
Hobbs, B. A. Comparing models for measuring ring strain of common cycloalkanes. Corinthian 6, 4 (2004).
Kanno, T. et al. Literature review of the role of hydroxyl radicals in chemically-induced mutagenicity and carcinogenicity for the risk assessment of a disinfection system utilizing photolysis of hydrogen peroxide. J. Clin. Biochem. Nutr. 51, 9–14 (2012).
pubmed: 22798706
pmcid: 3391867
doi: 10.3164/jcbn.11-105
Spierto, F. W., Hannon, W. H., Gunter, E. W. & Smith, S. J. Stability of urine creatinine1Use of trade names is for identification purposes only and does not constitute endorsement by the Public Health Service, or by the U.S. Department of Health and Human Services 1. Clin. Chim. Acta 264, 227–232 (1997).
pubmed: 9293380
doi: 10.1016/S0009-8981(97)00080-6
Fuller, N. J. & Elia, M. Factors influencing the production of creatinine: Implications for the determination and interpretation of urinary creatinine and creatine in man. Clin. Chim. Acta 175, 199–210 (1988).
pubmed: 3416481
doi: 10.1016/0009-8981(88)90096-4
Remer, T., Montenegro-Bethancourt, G. & Shi, L. Long-term urine biobanking: Storage stability of clinical chemical parameters under moderate freezing conditions without use of preservatives. Clin. Biochem. 47, 307–311 (2014).
pubmed: 25239781
doi: 10.1016/j.clinbiochem.2014.09.009
Stevens, V. L., Hoover, E., Wang, Y. & Zanetti, K. A. Pre-analytical factors that affect metabolite stability in human urine, plasma, and serum: A review. Metabolites 9, 156 (2019).
pubmed: 31349624
pmcid: 6724180
doi: 10.3390/metabo9080156
Rotter, M. et al. Stability of targeted metabolite profiles of urine samples under different storage conditions. Metabolomics 13, 4 (2017).
pubmed: 27980503
doi: 10.1007/s11306-016-1137-z
Saude, E. J. & Sykes, B. D. Urine stability for metabolomic studies: Effects of preparation and storage. Metabolomics 3, 19–27 (2007).
doi: 10.1007/s11306-006-0042-2
Bao, Y. & Zuo, L. Effect of repeated freeze-thaw cycles on urinary albumin-to-creatinine ratio. Scand. J. Clin. Lab. Investig. 69, 886–888 (2009).
doi: 10.3109/00365510903323209
Zhang, Y. et al. Effect of freeze/thaw cycles on several biomarkers in urine from patients with kidney disease. Biopreserv. Biobank. 13, 144–146 (2015).
pubmed: 25880475
doi: 10.1089/bio.2014.0033
Gómez, C. et al. Quantitative metabolic profiling of urinary eicosanoids for clinical phenotyping. J. Lipid Res. 60, 1164–1173 (2019).
pubmed: 30842246
pmcid: 6547631
doi: 10.1194/jlr.D090571
Olson, M. T. et al. Effect of assay specificity on the association of urine 11-dehydro thromboxane B2 determination with cardiovascular risk. J. Thromb. Haemost. 10, 2462–2469 (2012).
pubmed: 23072449
pmcid: 3718475
doi: 10.1111/jth.12026
Yan, Z., Mas, E., Mori, T. A., Croft, K. D. & Barden, A. E. A significant proportion of F2-isoprostanes in human urine are excreted as glucuronide conjugates. Anal Biochem 403, 126–128 (2010).
pubmed: 20406619
doi: 10.1016/j.ab.2010.04.016
Cunningham, T. J. et al. Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroinflammation 3, 26 (2006).
pubmed: 16965627
pmcid: 1592473
doi: 10.1186/1742-2094-3-26
Downey, P. et al. Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2). Am. J. Physiol. Renal Physiol. 280(4), F607-618 (2001).
pubmed: 11249852
doi: 10.1152/ajprenal.2001.280.4.F607
Cunningham, T. J., Yao, L. & Lucena, A. Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines’ unexpected therapeutic properties. J. Inflamm. 5, 17 (2008).
doi: 10.1186/1476-9255-5-17
Fabris, C. et al. Urinary phospholipase A2 excretion in chronic pancreatic diseases. Int. J. Pancreatol. 11, 179–184 (1992).
pubmed: 1517657
doi: 10.1007/BF02924183
Najafi, A. et al. Supplementation of freezing and thawing media with brain-derived neurotrophic factor protects human sperm from freeze-thaw-induced damage. Fertil. Steril. 106, 1658–1665 (2016).
pubmed: 27717551
doi: 10.1016/j.fertnstert.2016.09.004
Bahmyari, R., Zare, M., Sharma, R., Agarwal, A. & Halvaei, I. The efficacy of antioxidants in sperm parameters and production of reactive oxygen species levels during the freeze-thaw process: A systematic review and meta-analysis. Andrologia 52, e13514 (2020).
pubmed: 31967363
doi: 10.1111/and.13514
Len, J. S., Koh, W. S. D. & Tan, S. X. The roles of reactive oxygen species and antioxidants in cryopreservation. Biosci. Rep. 39, BSR20191601 (2019).
pubmed: 31371631
pmcid: 6712439
doi: 10.1042/BSR20191601